CASI Pharmaceuticals (CASI) Net Income (2022 - 2025)
Historic Net Income for Pharmaceuticals (CASI) over the last 4 years, with Q2 2025 value amounting to -$10.8 million.
- Pharmaceuticals' Net Income fell 2802.46% to -$10.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$29.4 million, marking a year-over-year decrease of 1384.49%. This contributed to the annual value of -$38.1 million for FY2024, which is 4356.45% down from last year.
- Per Pharmaceuticals' latest filing, its Net Income stood at -$10.8 million for Q2 2025, which was down 2802.46% from -$10.1 million recorded in Q1 2025.
- Pharmaceuticals' Net Income's 5-year high stood at -$3.3 million during Q4 2023, with a 5-year trough of -$14.9 million in Q4 2022.
- Over the past 4 years, Pharmaceuticals' median Net Income value was -$7.8 million (recorded in 2023), while the average stood at -$8.1 million.
- Data for Pharmaceuticals' Net Income shows a peak YoY increase of 7782.11% (in 2023) and a maximum YoY decrease of 4747.3% (in 2023) over the last 5 years.
- Pharmaceuticals' Net Income (Quarter) stood at -$14.9 million in 2022, then surged by 77.82% to -$3.3 million in 2023, then tumbled by 156.48% to -$8.5 million in 2024, then fell by 28.02% to -$10.8 million in 2025.
- Its last three reported values are -$10.8 million in Q2 2025, -$10.1 million for Q1 2025, and -$8.5 million during Q2 2024.